During the corresponding time, Icad Inc saw a revenue deteriorated by -1.61 % year on year, sequentially revenue grew by 9.9 %. While revenue at the Icad Inc's corporate clients
Icad Inc's Comment on Sales, Marketing and Customers
iCAD provides the ProFound Breast Health Suite, an AI-based solution for mammography interpretation used in over 40 million mammograms in the past five years. Its products are available in more than 50 countries. The company operates as a platform-based SaaS/DaaS organization through ProFound Cloud, serving healthcare providers involved in breast cancer screening and diagnosis worldwide. iCAD focuses on expanding its direct and indirect sales channels and geographic presence to grow its business.
Revolutionizing Mammography: iCAD and Microsoft s Precision Imaging Network Collaboration In a significant advancement for the healthcare and radiology sectors, iCAD, a global leader in medical technologies, has announced its collaboration with Microsoft to enhance mammography services. This strategic partnership will enable the integration of iCAD s innovative mammography solutions within Microsoft’s Precision Imaging Network (PIN), further modernizing radiological procedures and amplifying the efficacy of early breast cancer detection.The collaboration aims to empower radiology providers by offering a seamless, automated patient reporting system through the integration with PowerScribe, a renowned radiol...
In the ever-evolving battle against breast cancer, a paradigm shift is on the horizon as iCAD, a leading innovator in medical technologies, unveils a suite of next-generation AI solutions set to reshape the landscape of early detection and diagnosis. At the upcoming Radiological Society of North America (RSNA) 2024 conference, iCAD will showcase its FDA-cleared advancements, developed to augment accuracy and clinical efficiency in mammography. Coupled with a novel second-read AI partnership with Cascaid Health, this initiative sets the stage for a new era in breast cancer care.Central to these innovations is ProFound Health, a virtual care partnership with Cascaid Health poised to democratize access to AI-po...
iCAD, Inc. (NASDAQ: ICAD), a globally recognized leader in AI-powered cancer detection solutions, is set to make a remarkable impression at the upcoming Society for Breast Imaging (SBI) annual symposium in Montreal, Canada. The company will showcase its ProFound Breast Health Suite of AI solutions, including the highly anticipated ProFound Cloud, powered by Google Cloud and Google Health AI architecture. This groundbreaking development revolutionizes breast health screening by leveraging the power of artificial intelligence in collaboration with these tech giants.iCAD s strategic partnership with Densitas, another trailblazer in AI-enabled breast cancer screening, will also take center stage at the symposium...
Breast cancer continues to be a significant global health concern, affecting millions of lives worldwide. While early detection is key to successful treatment outcomes, access to quality healthcare and accurate diagnosis remains a challenge in underserved regions and low- and middle-income countries (LMICs). However, a groundbreaking partnership between iCAD and RAD-AID, leveraging the power of Artificial Intelligence (AI) technology, shows immense promise in overcoming these barriers and transforming breast cancer detection in vulnerable communities.Enhancing Breast Cancer Diagnosis through ProFound AI Detection:iCAD, a global leader in cancer detection and therapy solutions, has brought its cutting-edge te...
Icad Inc’s Comment on Sales, Marketing and Customers
iCAD provides the ProFound Breast Health Suite, an AI-based solution for mammography interpretation used in over 40 million mammograms in the past five years. Its products are available in more than 50 countries. The company operates as a platform-based SaaS/DaaS organization through ProFound Cloud, serving healthcare providers involved in breast cancer screening and diagnosis worldwide. iCAD focuses on expanding its direct and indirect sales channels and geographic presence to grow its business.
Sources:
Icad Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Icad Inc’s corporate clients.
For your research, we’ve provided 9 tables on Icad Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
76.14 %